Separately, a cytokine screen of CML patient samples identified myostatin propeptide (MSTNpp) to significantly stimulate CD34+CD38low proliferation in vitro, independently of its known ligand myostatin. The gene discussed is MSTN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.